Filter
90
Text search:
Roche
Diagnostics
Featured
Recommendations
11
New Publications
26
Language
Document type
No document type
48
Guidelines
19
Studies & Reports
9
Fact sheets
8
Manuals
4
Situation Updates
1
Resource Platforms
1
Countries / Regions
Germany
3
Kenya
3
Global
3
Uganda
2
India
2
Tanzania
2
Mozambique
2
Senegal
1
Ethiopia
1
Ghana
1
Philippines
1
Zambia
1
South Africa
1
Peru
1
Brazil
1
North Macedonia
1
Latin America and the Carribbean
1
Western and Central Europe
1
Eastern Europe
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
25
Clinical Guidelines
11
Pharmacy & Technologies
9
Women & Child Health
3
Public Health
1
Toolboxes
TB
15
HIV
14
COVID-19
14
Rapid Response
5
Zika
5
Ebola
3
Refugee
3
Global Health Education
3
AMR
3
Pharmacy
2
NTDs
2
NCDs
2
Health Financing Toolbox
1
L’expansion de la mise en œuvre des approches de suivi du traitement par la réalisation de tests de mesure de la charge virale et de tests de diagnostic chez le nourrisson sera indispensable pour garantir la qualité des soins et des traitements ainsi que le succès des programmes. Le fait de ch
...
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021
TECHNICAL SPECIFICATIONS FOR TEST SELECTION ESSENTIAL IN VITRO DIAGNOSTIC TESTS FOR SARS-COV-2
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. These guidelines include laboratory design considerat
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it
...
This document provides a systematic approach in developing a coordinated, standardized, reliable, efficient, cost-effective, and sustainable specimen transport and referral system to support IVHD and VL testing networks. This document provides technical and programmatic recommendations on the approp
...
Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi
...
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical man
...
Protocol and preliminary evaluationas of Jan 17, 2020
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio
...
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
Intensificar o reforço das abordagens de monitorização do tratamento através dos testes da carga viral, assim como o diagnóstico pediátrico precoce, será fundamental para garantir cuidados e tratamentos de boa qualidade e o êxito dos programas. Considerar uma boa rede de diagnósticos, tipos
...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian
...
Bulletin of the World Health Organization; http://dx.doi.org/10.2471/BLT.16.176677
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
